Clinical Trials
25 trialsSunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
SNIPP
University Health Network, Toronto
SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer
Universitaire Ziekenhuizen KU Leuven
Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery
Federation Francophone de Cancerologie Digestive
MERECA
Mendus
SURF
Centre Hospitalier Universitaire de Besancon
NIVOSWITCH
AIO-Studien-gGmbH
SUAVE
The Clatterbridge Cancer Centre NHS Foundation Trust
SuAx
Instituto do Cancer do Estado de São Paulo
A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Eli Lilly and Company
Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)
National University Hospital, Singapore
MetAction
Oslo University Hospital
KOSMIC
Seoul National University Hospital
Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
SUNRISES
Associació per a la Recerca Oncologica, Spain
SUNLAND
GERCOR - Multidisciplinary Oncology Cooperative Group
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Massachusetts General Hospital
Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma
Memorial Sloan Kettering Cancer Center
A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
University Health Network, Toronto
Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases
Case Comprehensive Cancer Center
Study of SU11248 in Men With Advanced Prostate Cancer
Massachusetts General Hospital
Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization
H. Lee Moffitt Cancer Center and Research Institute
SMAT
Association of Urologic Oncology (AUO)
Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)
Korean Urological Oncology Society